Bellevue Asset Management (Switzerland)’s Novavax NVAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q4
$2.73M Hold
16,250
0.42% 72
2015
Q3
$2.3M Sell
16,250
-9,750
-38% -$2.19M 0.37% 79
2015
Q2
$5.79M Hold
26,000
0.8% 45
2015
Q1
$4.3M Buy
+26,000
New +$4.22M 0.6% 58

Other funds holding NVAX

Bellevue Asset Management (Switzerland)'s NVAX Position: Q4 2015 in Review

Bellevue Asset Management (Switzerland) held its Novavax (NVAX) position steady in Q4 2015 at 16,250 shares worth $2.73M. The position accounts for 0.42% of the portfolio, ranked #72.

Bellevue Asset Management (Switzerland) first reported a position in NVAX in Q1 2015 and has held it in 4 quarters since. The position peaked at $5.79M in Q2 2015. 173 funds tracked by Wall St. Rank hold NVAX as of Q4 2015.

  • Bellevue Asset Management (Switzerland) held 16,250 shares of Novavax worth $2.73M as of Q4 2015.
  • Bellevue Asset Management (Switzerland) left its Novavax share count unchanged in Q4 2015.
  • Novavax made up 0.42% of Bellevue Asset Management (Switzerland)'s portfolio in Q4 2015, its #72 holding.
  • Bellevue Asset Management (Switzerland) first reported a position in Novavax in Q1 2015 and has held it in 4 quarters since.
  • Bellevue Asset Management (Switzerland)'s Novavax position peaked at $5.79M in Q2 2015.
  • 173 funds tracked by Wall St. Rank held Novavax as of Q4 2015.

Based on Bellevue Asset Management (Switzerland)'s 13F filing for Q4 2015, filed 12 Feb 2016.